Výsledky vyhledávání

Akademický článek

Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors

Autor: Hong-tao Guo, Xue-han Bi, Ting Lei, Xiao Lv, Guang Yao, Yao Chen, Chang Liu

Publikováno v: BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)

Abstract Background For cervical cancer patients whose tumors display a combination of intermediate risk factors, postoperative radiation with or without adjuvant chemotherapy is suggested for them. However, who should be administered with adjuvant c

Externí odkaz: https://doaj.org/article/c66d8631f2dd46909e78a2e85a0b25c8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Anlotinib combined with TQB2450 in patients with platinum-resistant or -refractory ovarian cancer: A multi-center, single-arm, phase 1b trial

Autor: Chun-Yan Lan, Jing Zhao, Fan Yang, Ying Xiong, Rong Li, Yu Huang, Jing Wang, Chang Liu, Xue-Han Bi, Hai-Hong Jin, Jin Meng, Wei-Hong Zhao, Li Zhang, Ya-Fei Wang, Min Zheng, Xin Huang

Publikováno v: Cell reports. Medicine. 3(7)

This is a phase Ib study of anlotinib plus a programmed death-ligand 1 (PD-L1) inhibitor TQB2450 for platinum-resistant or -refractory ovarian cancer. Thirty-four patients are enrolled and receive treatment. The objective response rate (ORR) is 47.1%

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c127d6f385546b4fc0a9630043daff87
https://pubmed.ncbi.nlm.nih.gov/35858589

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání